Stay updated with breaking news from Pharma Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A long build-up was seen in 71 stocks, including BHEL, Dr Lal PathLabs, Balrampur Chini Mills, Granules India, and ONGC. An increase in open interest (OI) and price indicates a build-up of long positions.
On Monday, 2107 stocks advanced, 1665 declined and 170 remained unchanged, with an advance decline ratio of 1.27 on the Bombay Stock Exchange (BSE), indicating a positive closing of stocks in broader markets. Given the global macroeconomic hurdles, India's robust growth has stood up well, giving investors the confidence to maintain bullish bets and pushing the benchmark Nifty above the 20,000 level. The seventh session of advance has occurred despite ongoing selling by foreign institutional investors.
On Monday, 2305 stocks advanced, 1439 declined and 197 remained unchanged, with an advance decline ratio of 1.60 on the Bombay Stock Exchange (BSE), indicating a positive closing of stocks in broader markets. Markets continued to rally despite turbulence and gained nearly half a percent. Recent domestic macroeconomic data releases have painted a favourable picture for the domestic markets, enabling them to maintain their momentum.
The said transaction is to be completed by September 15, 2023.
On Thursday, 2241 stocks advanced, 1436 declined and 130 remained unchanged on the Bombay Stock Exchange (BSE), with an advance decline ratio of 1.56 indicating a positive closing of stocks in broader markets.